FDA inspection
SOLA Pharmaceuticals LLC: FDA inspection ending Mar 22, 2019
FDA inspection 1088275 · No Action Indicated (NAI) · Baton Rouge, LA
Key facts
| Inspection ID | 1088275 |
|---|---|
| Firm | SOLA Pharmaceuticals LLC |
| FEI number | 3014030941 |
| Address | Attn: Keith Lanasa, 655 Highlandia Dr |
| City | Baton Rouge |
| State | LA |
| ZIP | 70810 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Mar 22, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data